© Reuters. The Takeda logo is seen at the research center in Cambridge, Massachusetts, U.S., November 26, 2018. REUTERS/Julie Steenhuysen/Files
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday its 12-month operating profit fell 9.5 percent from a year earlier.
Japan’s largest drugmaker posted an operating profit of 461 billion yen ($3.54 billion) in the year ended March 31.
That compares with an earlier estimate of 515 billion yen by the company and a consensus forecast of 509 billion yen in a Refinitiv poll of 15 analysts.
The company expects operating profit to rise to 520 billion yen this fiscal year.
(1 USD = 130.3700 yen)